Curcumin modulates cellular AP-1, NF-kB, and HPV16 E6 proteins in oral cancer

ecancermedicalscience

Volumn 9, Issue , 2015, Pages

  Mishra, Alok ^a,b,c   Kumar, Rakesh ^a,b,d   Tyagi, Abhishek ^a,b   Kohaar, Indu ^a,c   Hedau, Suresh ^a   Bharti, Alok C ^a   Sarker, Subhodeep ^a   Dey, Dipankar ^a   Saluja, Daman ^b   Das, Bhudev ^a,b,e  

^a Institute of Cytology and Preventive Oncology (ICMR)   (India)

^b UNIVERSITY OF DELHI   (India)

^c NATIONAL CANCER INSTITUTE   (United States)

^d MAYO CLINIC   (United States)

^e AMITY UNIVERSITY   (India)

Author keywords

Activator protein 1 (ap 1); Curcumin; Human papilloma virus (hpa); Nuclear factor kappab (nf kb); Transcription

Indexed keywords

CURCUMIN; HUMAN PAPILLOMAVIRUS TYPE 16 E6 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 1; PROTEIN E6; PROTEIN E7; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS RNA;

ARTICLE; CANCER INHIBITION; CELL LEVEL; CELL VIABILITY; CYTOTOXICITY; DNA BINDING; DNA EXTRACTION; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MOUTH CANCER; ORAL CANCER CELL LINE; PROTEIN DEGRADATION; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS ONCOGENE;

EID: 84934963035     PISSN: None     EISSN: 17546605     Source Type: Journal    
DOI: 10.3332/ecancer.2015.525     Document Type: Article

References (36)

1. Parkin DM et al (2001) Estimating the world cancer burden: Globocan 2000 Int J Cancer 94(2) 153-156 DOI: 10.1002/ijc.1440 PMID: 11668491
2. Zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application Nat Rev Cancer 2(5) 342-350 DOI: 10.1038/nrc798 PMID: 12044010
3. Ernster JA et al (2007) Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus Laryngoscope 117(12) 2115-2128 DOI: 10.1097/MLG.0b013e31813e5fbb PMID: 17891052
4. Butz K and Hoppe-Seyler K (1993) Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region J Virol 67(11) 6476-6486 PMID: 8411351 PMCID: 238084
5. Bernard HU and Apt D (1994) Transcriptional control and cell type specificity of HPV gene expression Arch Dermatol 130(2) 210-215 DOI: 10.1001/archderm.1994.01690020076013 PMID: 8304760
6. Cripe TP et al (1990) Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules New Biol 2(5) 450-463 PMID: 1963084
7. Offord EA and Beard P (1990) A member of the activator protein 1 family found in keratinocytes but not in fibroblasts required for transcription from a human papillomavirus type 18 promoter J Virol 64(10) 4792-4798 PMID: 2168967 PMCID: 247967
8. Fontaine V et al (2000) A functional NF-kappaB binding site in the human papillomavirus type 16 long control region Virology 272(1) 40-49 DOI: 10.1006/viro.2000.0363 PMID: 10873747
9. Rosl F et al (1997) Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription J Virol 71(1) 362-370 PMID: 8985358 PMCID: 191059
10. Werness BA, Levine AJ and Howley PM (1990) Association of human papillomavirus types 16 and 18 E6 proteins with p53 Science 248(4951) 76-79 DOI: 10.1126/science.2157286 PMID: 2157286
11. Dyson N et al (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product Science 243(4893) 934-937 DOI: 10.1126/science.2537532 PMID: 2537532
12. Abate C et al (1990) Redox regulation of fos and jun DNA-binding activity in vitro Science 249(4973) 1157-1161 DOI: 10.1126/science.2118682 PMID: 2118682
13. Toledano MB and Leonard WJ (1991) Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro Proc Natl Acad Sci USA 88(10) 4328-4332 DOI: 10.1073/pnas.88.10.4328 PMID: 1903539 PMCID: 51652
14. Baeuerle PA The inducible transcription activator NF-kappa B: regulation by distinct protein subunits Biochim Biophys Acta 1072(1) 63-80 PMID: 2018779
15. Li CJ et al (1993) Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication Proc Natl Acad Sci USA 90(5) 1839-1842 DOI: 10.1073/pnas.90.5.1839 PMID: 8446597 PMCID: 45975
16. Prusty BK and Das BC (2005) Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin Int J Cancer 113(6) 951-960 DOI: 10.1002/ijc.20668
17. Hahm ER et al (2002) New and known symmetrical curcumin derivatives inhibit the formation of Fos-Jun-DNA complex Cancer Lett 184(1) 89-96 DOI: 10.1016/S0304-3835(02)00170-2 PMID: 12104052
18. Huang TS, Lee SC and Lin JK (1991) Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells Proc Natl Acad Sci USA 88(12) 5292-5296 DOI: 10.1073/pnas.88.12.5292 PMID: 1905019 PMCID: 51858
19. Huang MT et al (1988) Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate Cancer Res 48(21) 5941-5946 PMID: 3139287
20. Krishnaswamy K et al (1998) Retardation of experimental tumorigenesis and reduction in DNA adducts by turmeric and curcumin Nutr Cancer 30(2) 163-1666 DOI: 10.1080/01635589809514657 PMID: 9589436
21. Sharma C et al (2006) Curcumin down regulates smokeless tobacco-induced NF-kappaB activation and COX-2 expression in human oral premalignant and cancer cells Toxicology 228(1) 1-15 DOI: 10.1016/j.tox.2006.07.027 PMID: 16996673
22. Singh S and Aggarwal BB (1995) Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected] J Biol Chem 270(42) 24995-25000 DOI: 10.1074/jbc.270.42.24995 PMID: 7559628
23. Aggarwal BB, Kumar A and Bharti AC (2003) Anticancer potential of curcumin: preclinical and clinical studies Anticancer Res 23(1A) 363-398 PMID: 12680238
24. Steenbergen RD et al (1995) Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line Cancer Res 55(22) 5465-5471 PMID: 7585617
25. Mishra A et al (2006) Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: role of high risk human papillomavirus infection Int J Cancer 119(12) 2840-2850 DOI: 10.1002/ijc.22262 PMID: 16998793
26. Mishra A et al (2010) Transactivation and expression patterns of Jun and Fos/AP-1 super-family proteins in human oral cancer Int J Cancer 126(4) 819-829
27. Eferl R and Wagner EF (2003) AP-1: a double-edged sword in tumorigenesis Nat Rev Cancer 3(11) 859-868 DOI: 10.1038/nrc1209 PMID: 14668816
28. Yoo GH et al (2002) The effects of exogenous p53 overexpression on HPV-immortalized and carcinogen transformed oral keratinocytes Cancer 94(1) 159-166 DOI: 10.1002/cncr.10210 PMID: 11815972
29. Divya CS and Pillai MR (2006) Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis Mol Carcinog 45(5) 320-332 DOI: 10.1002/mc.20170 PMID: 16526022
30. Rampias T et al (2007) Retrovirus-mediated delivery of short hairpin RNA targeting human papillomavirus (HPV) 16 E6 and E7 oncogenes and induction of apoptosis in oropharyngeal squamous cell cancer (OSCC) cell line J Clin Oncol ASCO Annual Meeting Proceedings Part I 25(18S) 6002
31. Rampias T et al (2009) E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells J Natl Cancer Inst 101(6) 412-423 DOI: 10.1093/jnci/djp017 PMID: 19276448
32. Yuan H et al (2005) Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis Oncogene 24(32) 5069-5078 DOI: 10.1038/sj.onc.1208691 PMID: 15856013
33. Chu ZL et al (1997) Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control Proc Natl Acad Sci USA 94(19) 10057-10062 DOI: 10.1073/pnas.94.19.10057 PMID: 9294162 PMCID: 23303
34. Hong SY et al (2000) Involvement of two NF-kappa B binding elements in tumor necrosis factor alpha -, CD40-, and epstein-barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene J Biol Chem 275(24) 18022-18028 DOI: 10.1074/jbc.M001202200 PMID: 10751398
35. Aggarwal S et al (2004) Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling Int J Cancer 111(5) 679-692 DOI: 10.1002/ijc.20333 PMID: 15252836
36. Allen CT et al (2007) Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck Head Neck 29(10) 959-971 DOI: 10.1002/hed.20615 PMID: 17405170